Jordan Julie

Track

Insider profile

Performance

Overall performance
1.4
Performance over holding periods
1.4
30 days 90 days 120 days
Average return -20% 8.2% 15.1%
Success rate 9% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Jordan Julie's trades of Neurogene Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Neurogene Inc (NGNE)
Transaction date
Sale
Price
163.95
Quantity 58,366 -43.8%
Value US$556,660
US Q32 Bio Inc (QTTB)
Transaction date
Sale
Price
158.40
Quantity 61,236 +18.3%
Value US$153,722
US Q32 Bio Inc (QTTB)
Transaction date
Planned sale
Price
225.62
Quantity 84,788 +5.1%
Value US$3,211,944
US Q32 Bio Inc (QTTB)
Transaction date
Planned sale
Price
1.39
Quantity 436 -10.1%
Value US$606
US Q32 Bio Inc (QTTB)
Transaction date
Planned sale
Price
1.31
Quantity 99 -3.5%
Value US$130
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-30 2026-03-26
US Neurogene Inc (NGNE)
S Sale
58,366 -43.8%
163.95
US$556,660 		58,366 -43.8% 163.95 US$556,660
2023-08-07 2023-08-03
US Q32 Bio Inc (QTTB)
S Sale
61,236 +18.3%
158.40
US$153,722 		61,236 +18.3% 158.40 US$153,722
2023-08-07 2023-08-03
US Q32 Bio Inc (QTTB)
PlS Planned sale
84,788 +5.1%
225.62
US$3,211,944 		84,788 +5.1% 225.62 US$3,211,944
2023-08-07 2023-08-03
US Q32 Bio Inc (QTTB)
PlS Planned sale
436 -10.1%
1.39
US$606 		436 -10.1% 1.39 US$606
2023-08-04 2023-08-02
US Q32 Bio Inc (QTTB)
PlS Planned sale
99 -3.5%
1.31
US$130 		99 -3.5% 1.31 US$130